Feng Zhu
- Cancer Research top 5%
- MicroRNA in disease regulation 8
- Cancer-related molecular mechanisms research 8
- Biological Psychiatry top 10%
- Molecular Biology top 10%
- Signaling Pathways in Disease 5
- Receptor Mechanisms and Signaling 5
- Extracellular vesicles in disease 4
- Immunology top 10%
- Immune cells in cancer 7
-
- Liver Disease Diagnosis and Treatment 4
-
- Inflammatory Bowel Disease 4
- Partner nations
- ChinaUnited KingdomUnited States
In The Last Decade
Feng Zhu
61 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 106
- Cancer Research 423
- Biological Psychiatry 59
- Molecular Biology 948
- Immunology 242
- Behavioral Neuroscience 31
Countries citing papers authored by Feng Zhu
This map shows the geographic impact of Feng Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng Zhu more than expected).
Fields of papers citing papers by Feng Zhu
This network shows the impact of papers produced by Feng Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng Zhu. The network helps show where Feng Zhu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Feng Zhu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 8 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 14 | |
| 5 | 2022 | 17 | |
| 6 | 2022 | 2 | |
| 7 | 2022 | 31 | |
| 8 | 2021 | 10 | |
| 9 | 2019 | 13 | |
| 10 | 2018 | 95 | |
| 11 | 2018 | 99 | |
| 12 | 2018 | 24 | |
| 13 | 2016 | 79 | |
| 14 | 2015 | 28 | |
| 15 | 2014 | 24 | |
| 16 | 2013 | 15 | |
| 17 | 2013 | 88 | |
| 18 | 2013 | 15 | |
| 19 | 2011 | 14 | |
| 20 | Abstract 2753: Observation of Long-Term Efficacy and Safety of an ATR12181 Vaccine Against Hypertension in SHR | 2006 | 4 |
About Feng Zhu
Feng Zhu is a scholar working on Cancer Research, Immunology and Neurology, having authored 62 papers that have together received 1.7k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (8 papers), Cancer-related molecular mechanisms research (8 papers), Immune cells in cancer (7 papers), Signaling Pathways in Disease (5 papers), Receptor Mechanisms and Signaling (5 papers), Extracellular vesicles in disease (4 papers), Liver Disease Diagnosis and Treatment (4 papers) and Inflammatory Bowel Disease (4 papers). The work is most often cited by research in Cancer Research (423 citations), Biological Psychiatry (59 citations) and Molecular Biology (948 citations). Feng Zhu has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Heng Fan, Yujin Liu, Hui Wu, Chen Tan, Hua Xiong, Yanmei Zou, Guoxiang Liu, Bing Li, Yalan Dong and Galya Vassileva. Their work appears in journals such as Circulation, Nature Communications and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.